Picture of Eris Lifesciences logo

ERIS — Eris Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

India's Eris Lifesciences to buy some dermatology brands from Glenmark Pharma

BENGALURU, Jan 17 (Reuters) - Indian drugmaker Eris
Lifesciences Ltd  ERIS  said on Tuesday it would acquire a
portfolio of dermatology brands from Glenmark Pharmaceuticals
Ltd  GLEN.NS  for 3.4 billion rupees ($41.63 million)
($1 = 81.6740 Indian rupees)
 (Reporting by Yagnoseni Das in Bengaluru; Editing by Shailesh
Kuber)
 ((Yagnoseni.Das@thomsonreuters.com; +91 6001289066))

Recent news on Eris Lifesciences

See all news